Articles Referencing CGIX
Cancer Genetics postpones $18 million IPO
3/19/2013, 9:15 am from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, postponed its IPO on
Tuesday, citing poor market conditions. The Rutherford,... Read >>
9 US IPOs planned for the week of Mar 18
3/18/2013, 8:00 am from Renaissance Capital in News Headlines, IPOs
The following IPOs are expected to price this week : Aviv REIT ( AVIV ), a rEIT
specializing in post-acute and long-term care skilled nursing
facilities, plans to raise $251 million by... Read >>
US IPO Weekly Recap: Calendar quickly builds, Silver Spring jumps in debut
3/15/2013, 6:16 pm from Renaissance Capital in News Headlines, IPOs
After several companies set terms last week, the US IPO Calendar is packed for the week of
March 18. Nine deals are scheduled to price, which would mark the
busiest week since the... Read >>
Diagnostics company Cancer Genetics cuts deal size to $18 million
3/11/2013, 3:38 pm from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, announced terms for
its IPO on Monday. The Rutherford, NJ-based company plans to... Read >>
Diagnostics company Cancer Genetics again decreases proposed deal size
3/4/2013, 10:45 am from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, lowered the proposed
deal size for its upcoming IPO on Monday. The Rutherford,... Read >>
Weekly Recap: Xoom zips, filing activity picks up for US IPO market
2/19/2013, 8:14 am from Renaissance Capital in News Headlines, IPOs
Money transfer service Xoom ( XOOM ) surged 59% on
Friday, ending 2013's first month and a half of US IPOs on a high
note. Xoom's first-day pop is another positive data point, together
with... Read >>
Cancer Genetics postpones second IPO attempt
2/15/2013, 7:44 am from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, postponed its IPO on
Friday. The company originally filed for an IPO in January 2012... Read >>
Cancer Genetics decreases proposed IPO deal size
2/14/2013, 8:11 am from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, lowered the proposed
deal size for its upcoming IPO on Thursday. The... Read >>
5 US IPOs planned for the week of Feb 11
2/11/2013, 7:00 am from Renaissance Capital in News Headlines, IPOs
The following IPOs are expected to price this week : AutoGenomics ( AGMX ), which provides
a molecular diagnostics system for genetic testing in clinical
laboratories, plans to raise $60... Read >>
Cancer Genetics relaunches deal with new underwriters
10/23/2012, 11:27 am from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, lowered the proposed
deal size for its upcoming IPO on Tuesday. The Rutherford,... Read >>
IPO activity remains slow despite Facebook offering
5/18/2012, 6:01 pm from Renaissance Capital in News Headlines, IPOs
Much of the air in the IPO market was filled with Facebook, as
it headlined what was a slow week in
IPO activity.
Only two other companies were on the calendar and neither was
... Read >>
Cancer Genetics postpones $48 million US IPO
5/17/2012, 6:10 pm from Renaissance Capital in News Headlines, IPOs
Cancer Genetics, which offers personalized genomic tests to
improve the diagnosis and treatment of cancer, postponed its IPO
on Thursday. The Rutherford, NJ-based company was founded... Read >>
3 US IPOs planned for the week of May 14
5/14/2012, 8:00 am from Renaissance Capital in Investing, IPOs
The following
IPOs are expected to price this week
:
Cancer Genetics
(
CGIX
), which offers personalized genomic tests to improve the
diagnosis and... Read >>
Diagnostics company Cancer Genetics sets terms for $48 million US IPO
5/7/2012, 11:00 am from Renaissance Capital in Investing, IPOs
Cancer Genetics, which offers proprietary genomic tests to
improve the diagnosis, prognosis and treatment of cancer,
announced terms for its IPO on Monday. The Rutherford, NJ-based
... Read >>